Research Progress and Critical Challenges of Bioartificial Kidneys in Renal Replacement Therapy for End-Stage Renal Disease
Biomolecules · 10.08.2026 · 16 (8) · 1161
DOI: 10.3390/biom16081161 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 10.08.2026. Verfasst von Luoyi Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Organ Transplantation Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China. Hauptthemen laut MEDLINE: Renal Replacement Therapy, Kidney Failure, Chronic, Kidneys, Artificial, Bioartificial Organs. Die Arbeit nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Guangdong Provincial Key Laboratory of Organ Medicine.
Abstract (Originalsprache)
Chronic kidney disease (CKD), one of the major global public health burdens, continues to exhibit a rising prevalence worldwide. The growing population of patients with end-stage renal disease (ESRD) has led to an increasing demand for renal replacement therapy (RRT). Although dialysis effectively prolongs survival, it fails to fully replicate kidney function. In addition, the persistent shortage of donor kidneys results in prolonged waiting periods for kidney transplantation. Emerging renal replacement strategies, such as kidney organoids, have demonstrated considerable potential. However, multiple technical limitations continue to hinder their near-term clinical translation. Bioartificial kidneys (BAKs), which integrate engineering and biological technologies, generally consist of artificial filtration membranes and living-cell bioreactors designed to mimic native kidney function. Advances in nanotechnology, biomaterials, and tissue engineering have accelerated the development of implantable bioartificial kidneys (iBAKs), making them an important research direction in renal replacement therapy. These innovations have improved membrane performance, biocompatibility, and cellular integration; however, substantial challenges remain regarding long-term stability, immune compatibility, and clinical validation before translation into human applications. Specifically, limited cell sources and uncertain long-term biocompatibility remain major barriers to iBAK development. In the future, biosensors and artificial intelligence (AI) technologies may be incorporated into bioartificial kidneys to enable personalized precision therapy. This review focuses on the developmental and major challenges of bioartificial kidneys, with detailed discussion of recent progress in implantable artificial kidneys.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Organ Transplantation Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
- Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
- NHC Key Laboratory of Clinical Nephrology, Guangdong Provincial Key Laboratory of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
- ARM Kidney Regeneration & Rebuilding Joint Lab, Sun Yat-sen University, Guangzhou 510080, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Guangdong Provincial Key Laboratory of Organ Medicine
- Sun Yat-sen University - ARM Kidney Regeneation & Rebuilding Joint Lab
- Sun Yat-sen University—ARM Kidney Regeneation & Rebuilding Joint Lab
- Science and Technology Department of Yunnan Province
Zitieren
APA
Chen, L., Zhang, Q., Tu, Y., Chen, T., Xie, Y., Lan, K., Yan, W., Xue, C., Yu, S., & Qiu, J. (2026). Research Progress and Critical Challenges of Bioartificial Kidneys in Renal Replacement Therapy for End-Stage Renal Disease. Biomolecules, 16(8), 1161. https://doi.org/10.3390/biom16081161
Vancouver
Chen L, Zhang Q, Tu Y, Chen T, Xie Y, Lan K, et al. Research Progress and Critical Challenges of Bioartificial Kidneys in Renal Replacement Therapy for End-Stage Renal Disease. Biomolecules. 2026;16(8):1161. doi:10.3390/biom16081161
BibTeX
@article{Chen2026,
author = {Chen, Luoyi and Zhang, Qiang and Tu, Yizhong and Chen, Tong and Xie, Yunliang and Lan, Kaixin and Yan, Wei and Xue, Chunyuan and Yu, Shuangjin and Qiu, Jiang},
title = {Research Progress and Critical Challenges of Bioartificial Kidneys in Renal Replacement Therapy for End-Stage Renal Disease},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {8},
pages = {1161},
doi = {10.3390/biom16081161}
}
EUVIMED